辉瑞公司(PFE.N)今日盘中股价大跌5.07%,引发了投资者的广泛关注。
消息面上,美国当选总统特朗普提名疫苗怀疑论者小罗伯特-肯尼迪(Robert F. Kennedy Jr.)领导卫生与公众服务部,这可能会助长公众对疫苗的疑虑,导致疫苗产品的市场需求受损。作为全球领先的疫苗生产商,辉瑞自然在在此事件中承受了股价下跌的压力。其他疫苗公司如BioNTech等也出现了不同程度的股价下跌。
与此同时,分析师指出如果该任命获得确认,可能会影响到生物技术行业投资情绪以及美国监管机构对该行业的支持力度。这无疑会对辉瑞等公司的长期发展造成潜在阻力。不过目前还难评估具体影响,需继续观察后续的政策走向。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.